In two small clinical studies presented at a meeting of the American Diabetes Association in San Francisco on Sunday, researchers said patients with Type 1 diabetes were able to better control their blood sugar when using an insulin-pump system controlled by an algorithm, or mathematical formula, which was embedded in a smartphone application, than when the patients determined the timing and dosage of injections themselves